(Q48095550)

8 February 2018

title

Gene expression signature is shared by patients with Alzheimer's disease and schizophrenia at the superior temporal gyrus. (English)

1 reference

8 February 2018

0 references

0 references

Y Horesh

1

1 reference

8 February 2018

P Katsel

series ordinal

2

1 reference

8 February 2018

V Haroutunian

series ordinal

3

1 reference

8 February 2018

E Domany

series ordinal

4

1 reference

8 February 2018

publication date

1 March 2011

1 reference

8 February 2018

European Journal of Neurology

published in

1 reference

8 February 2018

volume

18

1 reference

8 February 2018

issue

3

1 reference

8 February 2018

page(s)

410-424

1 reference

8 February 2018

The longitudinal stability of cognitive impairment in schizophrenia. Mini-mental state scores at one- and two-year follow-ups in geriatric in-patients.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Variations in differential gene expression patterns across multiple brain regions in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Disrupted in schizophrenia 1 and phosphodiesterase 4B: towards an understanding of psychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

The utility of MAS5 expression summary and detection call algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

The cAMP-specific phosphodiesterase 4B mediates Abeta-induced microglial activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

KEGG: kyoto encyclopedia of genes and genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Autophagosome formation: core machinery and adaptations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Human Apg3p/Aut1p homologue is an authentic E2 enzyme for multiple substrates, GATE-16, GABARAP, and MAP-LC3, and facilitates the conjugation of hApg12p to hApg5p

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Superior temporal gyrus in schizophrenia: a volumetric magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Autophagy in innate and adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Regulation and role of autophagy in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

A picky eater: exploring the mechanisms of selective autophagy in human pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Neurodegenerative lysosomal disorders: a continuum from development to late age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Regional rates of neocortical atrophy from normal aging to early Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Amyloid beta pathology in Alzheimer's disease and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Insulin and neurodegenerative disease: shared and specific mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

Tau protein abnormalities associated with the progression of alzheimer disease type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03166.X

10.1111/J.1468-1331.2010.03166.X

21 January 2018

Identifiers

DOI

1 reference

8 February 2018

PubMed ID

20695885

1 reference

8 February 2018